It keeps concentration constant across every draw within a single device and limits cold-chain handovers between 28 C storage events
Health Canada was explicit that many other unauthorized peptides exist and should all be avoided
Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
The recent surge in popularity of GLP-1 medications for weight loss can be attributed to their impressive results in clinical trials and their ability to address obesity and Type 2 diabetes